Suchergebnisse - "Kurokawa, Cheyne"

PubPharm (22)

1

Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus encoding IL-12

enthalten in: Molecular therapy. Oncology | 2024

von Kurokawa, C. | Agrawal, S. | Mitra, A. | +19

2

COMBINATIONS OF RECOMBINANT VIRUS EXPRESSING INTERLEUKIN-12 WITH PD-1/PD-L1 INHIBITORS

enthalten in: Europäisches Patentamt | 2024

von OBERST MICHAEL DAVID | BURKE SHANNON | KUROKAWA CHEYNE

3

Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma : a phase 1 trial

enthalten in: Nature communications | 2024

von Galanis, E. | Dooley, K. | Keith Anderson, S. | +19

4

Materials and methods for treating cancer

enthalten in: Europäisches Patentamt | 2024

von GALANIS EVANTHIA | ANDERSON S KEITH | KUROKAWA CHEYNE B | +1

5

Immunization of guinea pigs with cement extract induces resistance against Ixodes scapularis ticks

enthalten in: Ticks and tick-borne diseases | 2022

von Lynn, G. | Černý, J. | Kurokawa, C. | +7

6

Tick immunity using mRNA, DNA and protein-based Salp14 delivery strategies

enthalten in: Vaccine | 2021

von Matias, J. | Kurokawa, C. | Sajid, A. | +9

7

mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent

enthalten in: Science translational medicine | 2021

von Sajid, A. | Matias, J. | Arora, G. | +11

CommentIn: Sci Transl Med. 2021 Nov 17;13(620):eabm2504. - PMID 34788081

8

Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapy

enthalten in: The Journal of clinical investigation | 2021

von Panagioti, E. | Kurokawa, C. | Viker, K. | +8

9

Acquired tick resistance : The trail is hot

enthalten in: Parasite immunology | 2021

von Narasimhan, S. | Kurokawa, C. | DeBlasio, M. | +5

10

MATERIALS AND METHODS FOR TREATING CANCER

enthalten in: Europäisches Patentamt | 2021

von GALANIS EVANTHIA | ANDERSON S KEITH | KUROKAWA CHEYNE B | +1